These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 3730251)

  • 1. Human bladder cancer in vitro drug sensitivities: range and stability in long-term culture.
    Masters JR; Hepburn PJ
    Br J Cancer; 1986 Jul; 54(1):131-5. PubMed ID: 3730251
    [No Abstract]   [Full Text] [Related]  

  • 2. The value of adriamycin in overcoming resistance to methotrexate in tissue culture.
    Hill BT; Price LA; Goldies JH
    Eur J Cancer (1965); 1976 Jul; 12(7):541-9. PubMed ID: 986302
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenotypic drift and heterogeneity in response of metastatic mammary adenocarcinoma cell clones to adriamycin, 5-fluoro-2'-deoxyuridine and methotrexate treatment in vitro.
    Welch DR; Nicolson GL
    Clin Exp Metastasis; 1983; 1(4):317-25. PubMed ID: 6242707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
    Walker MC; Parris CN; Masters JR
    J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of 5-fluorouracil and methotrexate to destroy the reproductive integrity of a human breast cancer cell line (MCF-7) growing in vitro.
    Van den Berg HW; Clarke R; Murphy RF
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1275-81. PubMed ID: 7200028
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship between cytotoxic drug exposure and tumour cell kill, in vitro and in vivo.
    Kerr DJ; Smart HE
    In Vivo; 1991; 5(4):385-8. PubMed ID: 1810425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of clonogenic assay methodology on measurement of drug sensitivities in vitro.
    Hepburn PJ; Masters JR
    Cancer Chemother Pharmacol; 1986; 16(1):80-2. PubMed ID: 3940224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collateral sensitivity to methotrexate in cells resistant to adriamycin.
    Herman TS; Cress AE; Gerner EW
    Cancer Res; 1979 Jun; 39(6 Pt 1):1937-42. PubMed ID: 445393
    [No Abstract]   [Full Text] [Related]  

  • 9. An in vitro clonal assay for bladder cancer: studies of the biologic potential of the urothelium and determination of in vitro sensitivity to cytotoxic agents.
    Stanisic TH; Buick RN; Trent JM; Fry SE; Salmon SE
    J Surg Oncol; 1981; 18(1):67-72. PubMed ID: 7197316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Attempts to optimise colony-forming efficiencies using three different survival assays and a range of human tumour continuous cell lines.
    Hill BT; Whelan RD
    Cell Biol Int Rep; 1983 Aug; 7(8):617-24. PubMed ID: 6352062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro chemotherapy testing of transitional cell carcinoma.
    Shrivastav S; Paulson DF
    Invest Urol; 1980 Mar; 17(5):395-400. PubMed ID: 6153642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity of established human bladder carcinoma cell lines in vitro.
    Hisazumi H; Nakajima K; Uchibayashi T
    Gan; 1983 Feb; 74(1):176-82. PubMed ID: 6840436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of ultrasonic irradiation on doxorubicin-induced cytotoxicity in three human bladder cancer cell lines.
    Arthur C; Flaig T; Su LJ; Denney R; Barnes F; Glodé LM
    Ultrasonics; 2007 Mar; 46(1):68-73. PubMed ID: 17173946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of rifampicin on cultured human tumor cells.
    Winters WD; Tuan AL; Morton DL
    Cancer Res; 1974 Dec; 34(12):3173-9. PubMed ID: 4529664
    [No Abstract]   [Full Text] [Related]  

  • 15. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy.
    Knuchel R; Hofstadter F; Jenkins WE; Masters JR
    Cancer Res; 1989 Mar; 49(6):1397-401. PubMed ID: 2493980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytotoxic drug sensitivity of human normal and malignant lymphocyte-clone-forming cells.
    Matthews C; Kutlaca B; Seshadri R
    Int J Cell Cloning; 1987 Mar; 5(2):149-57. PubMed ID: 3471818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer.
    Zhou D; Zhang G; Gan Z
    J Control Release; 2013 Aug; 169(3):204-10. PubMed ID: 23388072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphatidylinositol- 3-kinase inhibitor induces chemosensitivity to a novel derivative of doxorubicin, AD198 chemotherapy in human bladder cancer cells in vitro.
    Smolensky D; Rathore K; Cekanova M
    BMC Cancer; 2015 Nov; 15():927. PubMed ID: 26597249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of resting 3T6 mouse fibroblasts to methotrexate cytotoxicity.
    Johnson LF; Fuhrman CL; Abelson HT
    Cancer Res; 1978 Aug; 38(8):2408-12. PubMed ID: 667839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant methotrexate, vinblastine, doxorubicin and cisplatin for histologically proven lymph node positive bladder cancer.
    Nieuwenhuijzen JA; Bex A; Meinhardt W; Kerst JM; Schornagel JH; VAN Tinteren H; Horenblas S
    J Urol; 2005 Jul; 174(1):80-5. PubMed ID: 15947583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.